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Background: Lifestyle Intervention for Weight Loss (LIFE-8) is developed as a structured, 
group-based weight management program for Emiratis with obesity and type 2 diabetes. It is a 
3-month program followed by a 1-year follow-up. The results from the first 2 years are presented 
here to indicate the possibility of its further adaptation and implementation in this region.
Methodology: We recruited 45 participants with obesity and/or type 2 diabetes based on 
 inclusion/exclusion criteria. The LIFE-8 program was executed by incorporating dietary 
modification, physical activity, and behavioral therapy, aiming to achieve up to 5% weight loss. 
The outcomes included body weight, fat mass, waist circumference, blood pressure, fasting 
blood glucose (FBG), hemoglobin A1c (HbA1c), and nutritional knowledge at 3 months and 
12 months.
Results: We observed a reduction of 5.0% in body weight (4.8±2.8 kg; 95% CI 3.7–5.8), 
fat mass (–7.8%, P,0.01), and waist circumference (Δ=4±4 cm, P,0.01) in the completed 
 participants (n=28). An improvement (P,0.05) in HbA1c (7.1%±1.0% vs 6.6%±0.7%) and FBG 
(8.2±2.0 mmol/L vs 6.8±0.8 mmol/L) was observed in participants with obesity and type 2 
diabetes after the program. Increase in nutritional knowledge (,0.01) and overall evaluation 
of the program (9/10) was favorable. On 1-year follow-up, we found that the participants 
could sustain weight loss (–4.0%), while obese, type 2 diabetic participants sustained HbA1c 
(6.6%±0.7% vs 6.4%±0.7%) and further improved (P,0.05) the level of FBG (6.8±0.8 mmol/L 
vs 6.7±0.4 mmol/L).
Conclusion: LIFE-8 could be an effective, affordable, acceptable, and adaptable lifestyle 
 intervention program for the prevention and management of diabetes in Emiratis. It was 
 successful not only in delivering a modest weight loss but also in improving glycemic control 
in diabetic participants.
Keywords: obesity, type 2 diabetes, UAE
Introduction
Obesity is an important public health problem around the world, and in the United Arab 
Emirates (UAE) approximately one in every three adults is obese.1 Rapid  urbanization 
leading to lifestyle factors such as overconsumption of calories and decreased physical 
activity offers a reasonable explanation for this.2 More than 80% individuals with type 2 
diabetes (T2D) are obese, indicating a strong correlation between obesity and T2D.3 
Obesity not only impedes the management of T2D by increasing insulin resistance 
and blood glucose concentration but is also reported to be an independent risk factor 
associated with dyslipidemia, hypertension, and cardiovascular disease.4,5 A moderate 
weight loss of 5% body weight is associated with the prevention of T2D progression in 
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Table 1 contents of each session in the lifestyle intervention for 
Weight loss (liFe-8)
Session Topic
session 1 (group) introduction to program
readiness assessment
Program expectation
session 2 (individual) Patient consent
nutritional assessment
sMarT goal setting
introduce pedometers and diet diaries 
(self-monitoring)
Diet planning




session 4 (group) healthy cooking methods
improvising traditional recipes
Practical cooking session
session 5 (individual) Diet and physical activity review
support and reward
session 6 (group) Problem-solving skills
Physical activity
Development of healthy recipe
session 7 (individual) nutritional assessment
session 8 (group) review of all sessions
Weight maintenance
Abbreviation: SMART, specific, measurable, achievable, relevant, and time-bound.





at-risk patients.6 It is also reported to improve insulin action 
and decrease the fasting blood glucose (FBG) concentrations 
in patients with T2D.7
Evidence-based guidelines for the management of obesity 
suggest a multidisciplinary approach, including a combina-
tion of diet, physical activity, and behavioral therapy.8 The 
effectiveness of low-fat, low-energy diets in combination with 
activity and lifestyle counseling has been demonstrated to 
result in 5%–10% weight loss and the reduction or preven-
tion of comorbidities such as diabetes and/or hypertension.9 
Recent guidelines also recommend group-based interven-
tions in weight management, as they are cost efficient and 
show increased effectiveness in specific behavior-change 
strategies.10
Landmark studies such as the Diabetes Prevention Pro-
gram and Look AHEAD have presented a strong role of 
lifestyle intervention in the prevention and management of 
T2D.7,11 One of the most challenging aspects is the imple-
mentation of these positive results from clinical trials into 
usual care due to deficiency of resources and expertise in 
the area of lifestyle management in this region. Translation 
of these programs in Arabia is scarce. Ali et al explored the 
barriers to weight management for Emirati women and sug-
gested the need for culturally acceptable, community-based 
interventions for the prevention and management of obesity 
among UAE women.12 A review of the demographic, social 
welfare, and behavioral variables and overweight prevalence 
in Arab countries has suggested that Arab women comprise a 
particularly vulnerable subgroup and the governments should 
act within religious and cultural parameters to provide envi-
ronments that are conducive to a negative energy balance.13
We, at the Rashid Centre for Diabetes and Research, 
aimed at developing a well-conceived, professionally imple-
mented, multidisciplinary, and group-based partial meal 
replacement/weight management program called Lifestyle 
Intervention for Weight Loss (LIFE-8). This ongoing pro-
gram’s overview and results for the first 2 years (October 
2012 to December 2014) are presented here to indicate the 




The LIFE-8 program was developed by the Lifestyle Clinic at 
Rashid Centre for Diabetes and Research, a tertiary care cen-
ter of diabetes and obesity in Ajman, UAE. Since this paper 
describes the structure and preliminary results of an evidence 
based clinical care program, ethical approval was not sought. 
LIFE-8 was designed to deliver weight loss through lifestyle 
modification combining diet therapy, physical activity, and 
behavioral modification. The multidisciplinary team included 
dietitians, an exercise therapist, a nurse coordinator, and a 
physician. This weight management program approach has 
evolved from previous lifestyle programs reported from 
similar conditions. The goals of this program were adapted 
on the basis of the available evidence, recommendation, and 
clinical experience of local dietary patterns of Emiratis.
Our main objective was to assess the weight change after 
LIFE-8 program; however, the secondary objectives were 
to assess the changes in fat mass, FBG, hemoglobin A1c 
(HbA1c), and the knowledge score.
LIFE-8 program was designed to introduce and empha-
size the following goals:
1. Limit cereal intake to 5–7 servings/d.
2. Increase vegetable intake to 3–4 servings/d.
3. Achieve physical activity of 7,000 steps/d–10,000 steps/d.
4. Encourage self-management skills for weight management.
Furthermore, the goals were individualized according 
to the need of the participant by a registered dietitian. This 
program was conveyed in eight sessions, ie, five groups and 
three individual sessions (Table 1). Individual sessions were 
utilized for the initial assessment, individualization of goals, 
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LIFE-8 program (12 weeks)
Completed
n=28
n=9 visit missed, n=8 withdrew
Based on readiness assessment
Excluded n=29 overweight, n=35
complications of T2D, n=68 T2D
more than 5 years
Figure 1 Flowchart of the program from screening to completion of liFe-8.
Abbreviations: T2D, type 2 diabetes mellitus; yrs, years; liFe-8, lifestyle intervention for Weight loss-8.
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and follow-up. Group sessions were utilized for education 
and participatory cooking. This program strongly emphasized 
empowering the participants to make the right choices and 
adapting to behavioral changes. A structured approach was 
used for the session execution; core topics were discussed 
with the help of a standardized presentation. Each session 
lasted between 60 minutes and 120 minutes with six to ten 
participants.
Participants
Our program was conducted in the Lifestyle Clinic, an 
outpatient setting attached to an educational kitchen. Par-
ticipants were registered through internal referrals and from 
other health care facilities in the Northern Emirates. The 
registrants were screened based on the following inclusion–
exclusion criteria: men and women of UAE nationality, age 
between 18 years and 50 years, obese (body mass index 
[BMI] $30 kg/m2) or obesity and with T2D (duration of 
diagnosis #5 years), and committed for a 3-month program. 
Participants were excluded if they had been diagnosed with 
T2D-associated complications or type 1 diabetes as well 
as pregnant or lactating women. Although 196 partici-
pants registered for this program, only 45 were recruited 
based on inclusion–exclusion criteria and their readiness 
to be assessed (Figure 1). Potential participants attended 
a group information meeting where the program details 
were discussed and readiness was assessed by a readiness 
assessment questionnaire adapted from the American 
Medical Association (2003),14 which recorded the reason 
to lose weight, family support interest, and readiness for a 
lifestyle change.
Eligible participants gave written consent of their partici-
pation in the program, and an initial nutritional assessment 
(60 minutes) was done to assess their FBG, HbA1c, blood 
pressure, body composition, waist circumference, usual 
dietary intake, and physical activity habits. The program was 
offered as a part of clinical care program, and there was no 
cost to the participant.






The initial assessment session included dietary recall (usual 
dietary recall), semistructured food frequency questionnaire, 
identification of individualized goals, and the handing over 
of the instructional material (diet plan, goal chart, food log, 
program schedule) developed by the registered dietitian. The 
suggested diet plan (1,200–1,500 cal/d) consisted of a combi-
nation of conventional balanced diet options as suggested by 
ADA guidelines and meal replacement as individualized by 
the dietitian. Two of the three main meals were replaced 
with a commercial meal replacement (Glucerna SR; Abbott 
Laboratories, Abbott Park, IL, USA) for 6 weeks, which 
contributed to 500 cal/d, followed by one meal replacement 
of 250 cal/d for the following 6 weeks. Participants were 
advised on an equal calorie meal if they found the meal 
replacements unpalatable.
Another essential component of the program was group 
sessions conducted by a registered dietitian. The participants 
were provided with instructions on healthy eating and diet 
planning. They were educated on food groups, sources of 
carbohydrate, portion sizes, cereal exchanges, vegetable 
portions, ideal plate model, improvisation of local recipes, 
food labels, and conscious eating.15 Hands-on interactive 
learning during the healthy cooking sessions was offered by 
dietitians, which facilitated the learning process by allow-
ing group interaction, engaging discussion, sharing cooking 
experiences, and the development of improvised healthy 
local recipes (Table 1).
Physical activity intervention
Improving physical activity was a strong focus of the pro-
gram. All the participants were provided with a pedometer as 
a mobile tool and could be tracked online by the participant/
counselor. A physical therapist provided a structured exercise 
session twice a week (45 minutes) focusing on aerobic exer-
cises, strength training, and stretching exercises. Participants 
were encouraged to incorporate moderate-intensity physical 
activity between 150 minutes/wk and 250 minutes/wk or a 
step count of 7,000–10,000 per day.16 However, the recom-
mendations were individualized based on the physical fitness 
and medical condition of the participant.
Behavioral modification intervention
Behavioral therapy helps the participants to make long term, 
sustainable changes in their eating pattern, physical activity, 
and control the environmental cues that stimulate eating.17 
Food diaries and pedometer activity records were advocated 
to inculcate the practice of self-monitoring. Additional 
emphasis was laid on recording the portions of cereals and 
vegetables. Educational sessions on the identification of 
 appetite, hunger, and environmental cues for trigger  eating 
were discussed as a stimulus control tool. The LIFE-8 
 program emphasized the need of specific, measurable, 
 achievable, relevant, and time-bound (SMART) goals for 
weight loss, since goal setting has been reported to encour-
age the adoption of behavioral change and offer as a tool 
for self-evaluation.18 Motivational interviewing strategies 
of empathy, self-efficacy, and rolling with resistance were 
adapted during the counseling sessions (Table 1).
Participant educational material
Educational material was developed on the topics discussed 
during the sessions to support and reinforce the information. 
Diet diaries, goal charts, tips on the identification of environ-
mental cues, physical activity, and healthy traditional recipes 
were made available for the participants.
Outcome measures
A pretested questionnaire was used to collect sociodemo-
graphic data, duration of diabetes, other medical conditions, 
and the history of weight loss. The outcomes were measured 
at 3 months on completion of the program. Nutritional 
knowledge was assessed by a pretested questionnaire before 
and after the program. Anthropometric measurements of 
height, weight, waist circumference, and body composition 
were taken with participants wearing light clothing and with-
out shoes by the same person. Body weight and height were 
recorded using an electronic balance with stadiometer 
(SECA, Germany) to the nearest 0.1 kg and 0.1 cm, respec-
tively. Body composition was assessed by bioelectric 
impedance using an InBody-230 instrument (Biospace, 
Dogok-dong, South Korea) under standardized conditions. 
The BMI (calculated as weight [kg]/height2 [m2]) was also 
estimated.
statistical analysis
All the data were subjected to descriptive analysis, normal 
distribution was confirmed by histogram plots, and the data 
were presented as mean ± SD. Differences between pre- 
and postintervention data were assessed using paired t-test. 
Primary analysis was conducted similar to the intention to 
treat for all recruited participants as well as for program 
completers. Inferences for comparison were tested at the 5% 
level of significance. All analyses were carried out with the 
Stata Statistical Software: Release 14 (StataCorp LP, College 
Station, TX, USA).
Diabetes, Metabolic syndrome and Obesity: Targets and Therapy 2016:9
Table 2 Demographic characteristics of participants at baseline




Participants with obesity 
and type 2 diabetes
recruited (n) 45 28 17
completed (n) 28 19 9
Female (%) 100 100 100
age (years), mean ± sD 42±9 40±9 46±9
Weight (kg), mean ± sD 98.2±19.4 97.0±19.1 100.6±20.9
Body mass index (kg/m2), mean ± sD 40.4±7.4 39.9±6.8 41.4±9
Educational attainment (% participant)
elementary school 16 7 33
high school 63 66 56
Bachelor’s degree 21 27 11
Reason to lose weight (% participant)
aesthetic purpose 8 13 0
improve health 54 40 78
improve quality of life 38 47 22
Tried to lose weight before (% participant)
Yes 96 100 100
no 4 0 0
Abbreviation: sD, standard deviation.
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Results
Screening of participants, enrollment, and the follow-
up sequence are shown in Figure 1, while the baseline 
characteristics are described in Table 2. The participants were 
divided based on obesity versus obesity with T2D, and no 
significant difference was recorded between these subgroups 
at baseline. Eighty-four percent of participants were reason-
ably educated, and the purpose of seeking the weight loss 
program was largely to improve health and the quality of life 
in both subgroups. Ninety-eight percent of total participants 
tried to lose weight through dietary restriction and exercises, 
with no success in weight maintenance.
Table 3 presents the changes in measures of body 
weight, fat mass, FBG, and HbA1c during the LIFE-8 
program. On analyzing the data for completers (n=28), 
we found a significant (P,0.01) weight loss of 4.8±2.8 kg 
(5.0%) (95% CI 3.7–5.8), fat loss 3.8±3.0 kg (7.8%) (95% 
CI 2.6–5.1), and reduction in waist circumference 4±4 cm 
(95% CI 1.8–5.6) after the 3-month program. On compar-
ing the two subgroups, we observed that both showed a 
significant (P,0.01) reduction in body weight, BMI, and 
fat mass. A significant improvement (P,0.01) in glycemic 
control (HbA1c and FBG) was observed in participants 
with obesity and T2D.
After 1-year follow-up of the completers (n=28), we 
found that they could maintain 4.0% weight loss (,0.001) 
compared to baseline (Figure 2). Participants with type 2 
diabetes (n=9) showed a sustained glycemic control after 
12 months with FBG (Table 4).
Participant feedback
Since evaluation and feedback are the key to learn and 
improve, all the participants were encouraged to fill a stan-
dardized knowledge questionnaire before and after the pro-
gram, the purpose of which was to study the changes in the 
nutritional knowledge, ie, self-monitoring, portion control, 
appetite control, common mistakes occurring during dietary 
intervention, food exchanges, ideal plate, food labeling, 
healthy cooking, and myths about weight loss. The average 
score had increased from 4/10 to 7/10 after the program 
(P,0.01). The sessions on weight maintenance, healthy 
cooking, and food labeling scored the highest. Visual analog 
scale ranging from 0 to 10 measured the overall acceptance 
of the program and was observed as 9/10. The cost of the 
program to the clinic was ∼US$160 per participant. How-
ever, this excluded the cost of meal replacements and the 
pedometer.
Discussion
These results indicate that the LIFE-8 program was suc-
cessful in translating evidence-based guidelines for weight 
management in clinical practice in the UAE. The outcome 
of this program encourages us to appreciate its benefits not 
only for contributing to weight loss and fat loss but also in 
improving the glycemic control inT2D participants.
This program was offered to participants with obesity 
and T2D after a thorough screening process based on the 
inclusion–exclusion criteria and readiness assessment. As 
reported earlier, assessing the readiness to change not only 
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Table 3 effect of liFe-8 program on anthropometric parameters and glycemic control in completers
Variable Total no of participants Participants with obesity Participants with obesity 
and T2D
Before After Before After Before After
Weight (kg) 98.2±19.4 93.4±19.4* 97.0±19.1 91.9±19.2* 100.6±20.9 96.7±20.5*
Body mass index (kg/m2) 40.4±7.4 38.4±7.4* 39.9±6.8 37.7±6.9* 41.4±9.0 39.8±8.6*
Fat mass (kg) 48.5±13.0 44.7±13.9* 47.4±12.6 43.8±13.1* 50.5±14.1 46.3±15.8*
Muscle mass (kg) 13.0±2.1 13.0±2.1 13±2.2 12.7±2.0 13.2±2.1 13.8±2.3
Water mass (kg) 36.4±6.1 36.0±6.0 36.2±6.6 34.9±5.9 36.9±6.3 37.8±6.3
Waist circumference (cm) 110±14 106±14* 103±11 99±11** 116±15 112±15**
Fasting blood glucose (mmol/l) – – 5.5±0.7 5.3±0.6 8.2±2.0 6.8±0.8**
hba1c (%) – – 5.6±0.3 5.5±0.3 7.1±1.0 6.6±0.7**
Notes: *P,0.01. **P,0.05. Data presented as mean ± sD.



















3 months 12 months
Figure 2 changes in body weight percentage during 1-year follow-up of the completed participants.





adds an extra step in facilitating the weight loss process but 
also indicates patient compliance.19–21 Although the program 
was developed and open for registration for both sex, very 
few male participants were registered, inadequate to form 
a group of 6–8. We observed that women seemed to more 
enthusiastic about participation unlike men, which could be 
due to the time demanded for this program, as it was offered 
during morning time on working days. Men were unable to 
confirm their attendance to the educational sessions at the 
clinic. The participants were divided into homogenous groups 
based on their age, educational level, and medical condition. 
The educational material and the teaching techniques varied 
marginally based on the conception of the participants in each 
group. The LIFE-8 program could deliver an average weight 
loss of 4.8±2.8 (5.0%) (program completers, n=28) and 3.2±2.8 
(3.2%) (recruited, n=45). This weight loss was comparable to 
the average weight loss reported in the systematic review and 
meta-analysis of 28 studies applying the findings of the Diabe-
tes Prevention Program across diverse settings and population, 
which showed a 4%–5% weight loss that was maintained for 
a follow-up period of 9 months.22 The weight loss was reflec-
tive of decreased (P,0.01) fat mass and waist circumference 
in the participants (7.8% and 3.7%). These observations are 
in consonance with the results of a meta-analysis of 56 stud-
ies in class II and III obese individuals showing that lifestyle 
interventions incorporating physical activity improved not only 
weight loss but also various cardiometabolic risk factors.23 
A significant improvement in the glycemic control was not 
only observed in the subgroup of participants with obesity 
and T2D (Table 4) but also in a small subgroup (n=6) with 
obesity and prediabetes, showing a substantial improvement 
(P=0.04) in HbA1c after the 3-month program (5.8% vs 5.5%). 
This could be attributed to clinically relevant health benefits 
of weight loss on glucose metabolism.24
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Fasting blood glucose 
(mmol/l)
8.2±2.0 6.8±0.8a 6.6±1.4a
hba1c (%) 7.1±1.0 6.6±0.7a 6.3±0.7a
Note: aSignificance compared with baseline (P,0.05).
Abbreviations: liFe-8, lifestyle intervention for Weight loss; hba1c, hemoglobin a1c.




lifestyle intervention for weight loss
This program could deliver equally effective results in 
eight sessions compared to programs offering more than eight 
sessions (∼4%) as described in a meta-analysis.22 Although 
a few studies have reported that the magnitude of weight 
loss is related to the number and frequency of sessions,25,26 
some have shown that programs of longer duration result 
in a higher dropout rate.27 Although we could not refer to 
similar programs in the Emirates, a 12-month intensive 
intervention in Arab women in this region has reported a 
decrease of 2.4±0.4 kg body weight, which is comparable 
to the results of this program.28 One of the major reasons for 
not having “translated” lifestyle intervention programs into 
routine  clinical practice is the cost incurred. Nevertheless, 
this program could be adapted in other clinical settings with 
a reasonable budget. With increased emphasis on the behav-
ioral modification throughout this program, we observed 
changes in participant perception and attitude toward eating 
behavior and physical activity.
One-year follow-up
A significant change (P,0.01) in body weight was observed 
after 1 year compared to baseline (∼4%). This result was 
comparable to the meta-analysis of 22 translational studies 
where the intervention arms showed a weight loss of 2.3 kg 
in 12 months.29 Emiratis women participating in LIFE-8 
could maintain their weight loss for 1 year, probably in part 
because they were more familiar, competent, and comfortable 
with the know-how of weight management and were able 
to practice it in grocery purchase, food preparation, meal 
portioning, increasing physical activity, and recognition of 
cues for overeating. We believe that these changes improve 
the  possibility of lasting weight loss. While the program 
delivered a modest weight loss, it could not continue further 
weight loss after the cessation of the intensive program.
A subgroup analysis of glycemic control in T2D partici-
pants (n=9) showed a significant improvement (P,0.05) in 
fasting plasma glucose (8.2±2.0 mmol/L vs 6.6±0.8 mmol/L) 
and HbA1c (7.1%±1.0% vs 6.3%±0.7%) even after 1 year 
of the program. Haimoto et al have reported a significant 
improvement in HbA1c after 2 years in patients with T2D 
on loose restriction of carbohydrate intake compared to 
conventional diet. However, whether the improvement in 
glycemic control is a result of weight loss or changes in total 
energy and nutrient intake is still being investigated.30 The 
National Health Interview Survey studied 1,401 overweight 
diabetic patients and reported that individuals trying to lose 
weight had 23% lower mortality rate than others, suggesting 
that eating less may have a beneficial effect in the long term 
even if weight loss is not achieved.31
The strength of this study is that this is one of the first 
evaluations of a lifestyle intervention program for obese 
and diabetic participants in this region. The program was 
developed based on available evidence and comprehen-
sive clinical experience with the local Emirati community. 
 However, the limitations to this study are the small sample 
size and its nonrandomized, pragmatic service assessment. 
The program has not been systematically compared with a 
control intervention program, and the sample included only 
women. Further evidence is required from a randomized, 
controlled trial to evaluate the short-term and long-term 
clinical advantages and cost-effectiveness of the LIFE-8 
program in this region. Since this is an ongoing program, 
further studies with a larger sample size could increase the 
generalizability of the program.
Conclusion
With a high prevalence of obesity and diabetes in the UAE, 
an effective, affordable, acceptable, and adaptable lifestyle 
intervention program could add to the efforts essential for 
the prevention and management of diabetes. The LIFE-8 
program was successful in not only delivering a modest 
weight loss but also inducing improvement in glycemic 
control in diabetic participants. In addition, participants 
also maintained their body weight after a 12-month follow-
up. However, there is a need for further analysis on a larger 
number of participants and execute the program in other 
health care facilities.
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